Showing results (41-50 of 235) with videos related to
Sort By:
Pageof 24
Transplantation Reviews (Orlando, Fla.)|January 17, 2017
Epstein-Barr virus and renal transplantationJade Le, Christine M Durand, Irfan Agha, et al.Trials|March 10, 2023
Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor's cellular immunotherapy products: the MDR-105-SAESam Kant, Dixon B Kaufman, Lenuta Micsa, et al.Transplantation|December 23, 2003
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimenWilliam Irish, Beth Sherrill, Daniel C Brennan, et al.Transplantation Direct|August 11, 2017
Quantitative Evaluation of the Impact of Ethylenediaminetetraacetic Acid Pretreatment on Single-Antigen Bead AssayChang Liu, Sue Pang, Donna Phelan, et al.Transplantation|September 24, 2005
Renal graft survival and calcineurin inhibitorRobert S Woodward, Andrea Kutinova, Mark A Schnitzler, et al.Microbiology Spectrum|June 25, 2024
Longitudinal alterations in the urinary virome of kidney transplant recipients are influenced by BK viremia and patient sexRabia Maqsood, Lily I Wu, Daniel C Brennan, et al.Journal of Nephrology|January 4, 2024
Twenty years in the making: tolerance in a living-related kidney transplant recipientManal Alotaibi, Ziad Alahmadi, Niraj Desai, et al.Trials|August 20, 2015
Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participantsKrista L Lentine, Mark A Schnitzler, Huiling Xiao, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 15, 2011
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporineRobert S Woodward, Marc C Flore, Gerardo Machnicki, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|November 2, 2004
Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetilKaren L Hardinger, Daniel C Brennan, Jeffrey Lowell, et al.Pageof 24